• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

• 投稿 • 上一篇    下一篇

医药上市企业盈余管理、政府补助与绩效的实证研究

朱培玲,徐怀伏   

  1. 中国药科大学国际医药商学院,中国药科大学国际医药商学院
  • 收稿日期:2017-10-11 修回日期:2017-10-19 出版日期:2017-12-25

Empirical Research on Earnings Management,Government Subsidies and Performance in Listed Pharmaceutical Enterprises

zhupeiling and XU Huaifu   

  1. School of International Pharmaceutical Business,Chinese Pharmaceutical Univercity,School of International Pharmaceutical Business,China Pharmaceutical University
  • Received:2017-10-11 Revised:2017-10-19 Online:2017-12-25

摘要: 目的:探讨医药上市企业盈余管理、政府补助与企业绩效三者之间的关系。方法:选取医药上市公司2011~2016年的相关数据,对三者关系进行回归分析。结果与结论:医药企业进行负向盈余管理将会获得更多的政府补助,且管理的程度越大,获得的政府补助也越多;政府补助在一定程度上有利于提高医药企业的绩效;医药企业运用负向盈余管理更会降低政府补助的边际价值,且管理的程度越大,政府补助的边际价值越低。

Abstract: Objective: To explore the relationship between earnings management, government subsidies and enterprise performance in listed pharmaceutical enterprises. Methods: Select the related data of listed pharmaceutical enterprises from 2011 to 2016, and the relationship between earnings management, government subsidies and enterprise performance was regressed. Results and conclusion: The pharmaceutical enterprises negative earnings management will get more government assistance, and the greater the degree of management, the more government subsidies to get; to a certain extent, government subsidies is conducive to the enterprise performance; the use of negative earnings management of pharmaceutical enterprises will reduce government subsidies marginal value, and the greater the degree of management, the lower the marginal value of government subsidies.